(Q33382467)

26 July 2017

1 reference

title

Determining glioma response to radiation therapy using recombinant peptides (English)

1 reference

adaptive radiation therapy

26 July 2017

main subject

0 references

author name string

Roberto Diaz

series ordinal

1

1 reference

26 July 2017

Ralph J Passarella

series ordinal

2

1 reference

26 July 2017

Dennis E Hallahan

series ordinal

3

1 reference

26 July 2017

publication date

1 November 2008

1 reference

Expert Review of Anticancer Therapy

26 July 2017

published in

1 reference

26 July 2017

volume

8

1 reference

26 July 2017

issue

11

1 reference

26 July 2017

page(s)

1787-1796

1 reference

26 July 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Neuro-oncology: the growing role of chemotherapy in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Current management of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Molecular imaging in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Latest advances in molecular imaging instrumentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Tomographic fluorescence mapping of tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer a

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Identification of novel targeting peptides for human ovarian cancer cells using "one-bead one-compound" combinatorial libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Tumor imaging by means of proteolytic activation of cell-penetrating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Annexin-V imaging for noninvasive detection of cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Therapeutic cancer targeting peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

The use of phage display for the development of tumour targeting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Towards proteome-wide production of monoclonal antibody by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Multimodality molecular imaging of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Radiation-Mediated Gene Expression in the Pathogenesis of the Clinical Radiation Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Tumour vasculature--a potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Anti-cancer activity of targeted pro-apoptotic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Organ targeting in vivo using phage display peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Display technologies: application for the discovery of drug and gene delivery agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Combinatorial discovery of tumor targeting peptides using phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Identification and characterization of novel human glioma-specific peptides to potentiate tumor-specific gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Neuroblastoma tumor cell-binding peptides identified through random peptide phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

RGD and other recognition sequences for integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

The alpha v beta 3 integrin "vitronectin receptor"

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Peptide ligands for integrin alpha v beta 3 selected from random phage display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.11.1787

10.1586/14737140.8.11.1787

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference